ACESO PLASMA LLC — Department of Defense SBIR Phase I: AF193-CSO1

Description

The Aceso Plasma Generator (APG) is a patented wound care device that accelerates healing while disinfecting and decontaminating the wound site. This technology achieves every aspect of the Air Forces strategic priority for Biotechnology to include disease prevention and mitigation, rapid emergency medical response and trauma management, environmental remediation, and advanced materials. The device creates low temperature, high concentration Reactive Oxygen Species (ROS) from ambient air which speed up the body’s own natural processes with regard to disinfection and healing. Oxygen has long been researched and used for treatment of hard to treat wounds and is noted for its disinfection and healing properties which is why patients are often treated in hyperbaric chambers. Military applications of this technology will allow more wounds to be treated locally, returning soldiers to the fight faster. The device would potentially decrease hospital stays, antibiotic use, dressing changes, and reduce healthcare costs. The objective of this project will be to define Air Force end user requirements to include form, fit, and function as well as research the studies required to achieve FDA approval to then commercialize the medical device. Completing the above tasks will make Aceso Plasma a strong candidate for a SBIR Phase II.